Arcus Biosciences, Inc. (RCUS) Balance Sheet Quarterly

Arcus Biosciences, Inc.

RCUS (NYSE)

(%)

Financials
Arcus Biosciences, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31
Report Filing:	2025-10-28	2025-08-06	2025-05-06	2025-02-25	2024-11-06	2024-08-08	1234
Total Current Assets	857	946	1,031	1,016	1,127	1,022	1234
Cash and Short Term Investments	831	911	997	978	1,089	969	1234
Cash & Equivalents	238	248	192	150	201	156	1234
Short Term Investments	593	663	805	828	888	813	1234
Receivables	14	20	21	25	21	33	1234
Inventory	0	0	0	0	0	0	1234
Other Current Assets	12	15	13	13	17	20	1234
Total Assets	974	1,075	1,156	1,150	1,252	1,186	1234
Total Non-Current Assets	117	129	125	134	125	164	1234
Property, Plant and Equipment	42	44	46	47	48	49	1234
Goodwill and Intangible Assets	0	0	0	0	0	0	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	0	0	0	0	0	0	1234
Long Term Investments	10	16	8	14	2	40	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	65	69	71	73	75	75	1234
Total Current Liabilities	235	210	192	226	215	199	1234
Accounts Payable	42	29	22	18	13	15	1234
Notes Payable/Short Term Debt	13	12	12	12	11	11	1234
Tax Payables	0	0	0	1	0	0	1234
Deferred Revenue	52	71	72	85	105	113	1234
Other Current Liabilities	128	98	86	110	86	60	1234
Total Liabilities	538	526	625	665	687	551	1234
Total Non-Current Liabilities	303	316	433	439	472	352	1234
Total Long Term Debt	98	97	48	48	47	0	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	53	60	219	234	0	214	1234
Capital Lease Obligations	13	12	12	12	11	11	1234
Other Long Term Liabilities	139	147	154	145	414	127	1234
Total Equity	436	549	531	485	565	635	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	436	549	531	485	565	635	1234
Retained Earnings	-1,379	-1,244	-1,244	-1,132	-1,038	-946	1234
Accumulated Other Earnings	0	0	0	0	1	-1	1234
Common Stock	1,815	1,793	1,775	1,617	1,602	1,582	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	0	0	0	0	0	0	1234
Total Liabilities & Total Equity	974	1,075	1,156	1,150	1,252	1,186	1234
Total Liabilities & Shareholders' Equity	974	1,075	1,156	1,150	1,252	1,186	1234
Total Investments	603	679	813	842	890	853	1234
Total Debt	111	109	60	60	58	11	1234
Net Debt	-127	-139	-132	-90	-143	-145	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Arcus Biosciences, Inc. Balance Sheet Statement Quarterly